MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D5E6AB.B1F29980"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01D5E6AB.B1F29980
Content-Location: file:///C:/68099CA5/UA179260101_1ECE.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA179260101_1ECE.files/filelist.xml">
<link rel=3DPreview href=3D"UA179260101_1ECE.files/preview.wmf">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Танасіюк Святослав Володимирович</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:LastPrinted>2019-01-25T14:38:00Z</o:LastPrinted>
  <o:Created>2020-02-18T20:35:00Z</o:Created>
  <o:LastSaved>2020-02-18T20:35:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>924</o:Words>
  <o:Characters>5273</o:Characters>
  <o:Company>Державний експертний центр</o:Company>
  <o:Lines>43</o:Lines>
  <o:Paragraphs>12</o:Paragraphs>
  <o:CharactersWithSpaces>6185</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DthemeData href=3D"UA179260101_1ECE.files/themedata.thmx">
<link rel=3DcolorSchemeMapping
href=3D"UA179260101_1ECE.files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:DefaultTableStyle Number=3D"0">Обычный</w:DefaultTableStyle>
  <w:DrawingGridHorizontalSpacing>0 пт</w:DrawingGridHorizontalSpacing>
  <w:DrawingGridVerticalSpacing>0 пт</w:DrawingGridVerticalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:DrawingGridHorizontalOrigin>0 пт</w:DrawingGridHorizontalOrigin>
  <w:DrawingGridVerticalOrigin>0 пт</w:DrawingGridVerticalOrigin>
  <w:Compatibility>
   <w:SpaceForUL/>
   <w:BalanceSingleByteDoubleByteWidth/>
   <w:DoNotLeaveBackslashAlone/>
   <w:ULTrailSpace/>
   <w:AdjustLineHeightInTable/>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2002TableStyleRules/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Mangal;
	panose-1:2 4 5 3 5 2 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:Mangal;
	panose-1:2 4 5 3 5 2 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147480833 14699 0 0 191 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
h2
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Обычный;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:28.8pt;
	margin-bottom:.0001pt;
	text-indent:-28.8pt;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:2;
	mso-list:l0 level2 lfo1;
	mso-hyphenate:none;
	tab-stops:list 0cm;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;
	mso-bidi-font-weight:normal;}
h4
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Обычный;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:43.2pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-43.2pt;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:4;
	mso-list:l0 level4 lfo1;
	mso-hyphenate:none;
	tab-stops:list 0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
h6
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Обычный;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:57.6pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-57.6pt;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:6;
	mso-list:l0 level6 lfo1;
	mso-hyphenate:none;
	tab-stops:list 0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	color:black;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:no-line-numbers;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;
	font-style:italic;}
p.MsoList, li.MsoList, div.MsoList
	{mso-style-unhide:no;
	mso-style-parent:"Основной текст";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-unhide:no;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
span.WW8Num1z0
	{mso-style-name:WW8Num1z0;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z1
	{mso-style-name:WW8Num1z1;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z2
	{mso-style-name:WW8Num1z2;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z3
	{mso-style-name:WW8Num1z3;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z4
	{mso-style-name:WW8Num1z4;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z5
	{mso-style-name:WW8Num1z5;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z6
	{mso-style-name:WW8Num1z6;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z7
	{mso-style-name:WW8Num1z7;
	mso-style-unhide:no;
	mso-style-parent:"";}
span.WW8Num1z8
	{mso-style-name:WW8Num1z8;
	mso-style-unhide:no;
	mso-style-parent:"";}
p.a, li.a, div.a
	{mso-style-name:Заголовок;
	mso-style-unhide:no;
	mso-style-next:"Основной текст";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:none;
	page-break-after:avoid;
	mso-hyphenate:none;
	font-size:14.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.1, li.1, div.1
	{mso-style-name:Указатель1;
	mso-style-unhide:no;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:no-line-numbers;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.31, li.31, div.31
	{mso-style-name:"Основной текст с отступом 31";
	mso-style-unhide:no;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:35.4pt;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.a0, li.a0, div.a0
	{mso-style-name:"Содержимое таблицы";
	mso-style-unhide:no;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:no-line-numbers;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.a1, li.a1, div.a1
	{mso-style-name:"Заголовок таблицы";
	mso-style-unhide:no;
	mso-style-parent:"Содержимое таблицы";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:no-line-numbers;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:Mangal;
	mso-font-kerning:1.0pt;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;
	font-weight:bold;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:2.0cm 2.0cm 2.0cm 2.0cm;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:1;
	mso-list-template-ids:1;}
@list l0:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level2
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:28.8pt;
	text-indent:-28.8pt;}
@list l0:level3
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level4
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:43.2pt;
	text-indent:-43.2pt;}
@list l0:level5
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level6
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:57.6pt;
	text-indent:-57.6pt;}
@list l0:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU style=3D'tab-interval:35.45pt;line-break:strict'>

<div class=3DWordSection1>

<h4 align=3Dcenter style=3D'text-align:center;mso-list:l0 level4 lfo1;tab-s=
tops:
0cm'><span lang=3DUK style=3D'mso-ansi-language:UK'>ІНСТРУКЦІЯ</span></h4>

<h2 align=3Dcenter style=3D'text-align:center;line-height:150%;page-break-a=
fter:
auto;mso-list:l0 level2 lfo1;tab-stops:0cm'><span lang=3DUK style=3D'font-s=
ize:
12.0pt;mso-bidi-font-size:10.0pt;line-height:150%;mso-ansi-language:UK'>для
медичного застосування </span><span lang=3DUK style=3D'font-size:12.0pt;lin=
e-height:
150%;letter-spacing:.1pt;mso-ansi-language:UK'>лікарського засобу</span></h=
2>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:20=
7.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'letter-spaci=
ng:.1pt;
mso-ansi-language:UK'>АРТИШОК</span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:20=
7.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'letter-spaci=
ng:.1pt;
mso-ansi-language:UK'>(</span></b><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DEN-US style=3D'letter-spacing:.1pt;mso-ansi-language:EN-US'>ARTICHOK=
E</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'letter-spaci=
ng:.1pt;
mso-ansi-language:UK'>)</span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-line-hei=
ght-alt:
5.0pt'><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Склад:</span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>діюча речовина: </span></i><span lang=3DEN-US
style=3D'mso-ansi-language:EN-US'>c</span><span class=3DSpellE><span lang=
=3DUK
style=3D'mso-ansi-language:UK'>ynara</span></span><span lang=3DUK style=3D'=
mso-ansi-language:
UK'> <span class=3DSpellE>scolymus</span>;</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
10.0pt;mso-ansi-language:UK'>1 мл розчину орального </span><span lang=3DUK
style=3D'mso-ansi-language:UK'>містить артишоку екстракту густого (</span><=
span
class=3DSpellE><i><span lang=3DEN-US style=3D'mso-ansi-language:EN-US'>Extr=
actum</span></i></span><i><span
lang=3DEN-US style=3D'mso-ansi-language:UK'> </span></i><span class=3DSpell=
E><i><span
lang=3DEN-US style=3D'mso-ansi-language:EN-US'>Cynarae</span></i></span><i>=
<span
lang=3DEN-US style=3D'mso-ansi-language:UK'> </span></i><span class=3DSpell=
E><i><span
lang=3DEN-US style=3D'mso-ansi-language:EN-US'>spissum</span></i></span><sp=
an
lang=3DUK style=3D'mso-ansi-language:UK'>) <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>(7,5 : 1) (екстрагент – вода очищена) у перерахуванні на артишоку екстр=
акт
сухий 100 мг;</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>допоміжні речовини:</span></i><span lang=3DUK
style=3D'mso-ansi-language:UK'> гліцерин, етанол 96 %, <span class=3DSpellE=
>метилпарабен</span>
(Е 218), <span class=3DSpellE>пропілпарабен</span> (Е 216), сорбіт (Е 420),
сахарин натрію, вода очищена.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-line-height-alt:5.0pt'=
><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-ansi-lan=
guage:
UK;mso-bidi-font-style:italic'>Лікарська форма. </span></b><span lang=3DUK
style=3D'mso-ansi-language:UK;mso-bidi-font-style:italic'>Розчин оральний.<=
/span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-line-height-alt:5.0pt'=
><i><span
lang=3DUK style=3D'mso-ansi-language:UK'>Основні фізико-хімічні властивості=
:<b> </b></span></i><span
lang=3DUK style=3D'mso-ansi-language:UK'>розчин від коричневого до
темно-коричневого кольору зі специфічним запахом. Допускається зеленуватий
відтінок, опалесценція та випадання осаду в процесі зберігання.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;layout-grid-mode:char'><sp=
an
class=3DSpellE><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK
style=3D'mso-ansi-language:UK'>Фармакотерапевтична</span></b></span><span
lang=3DUK style=3D'mso-ansi-language:UK'> <b style=3D'mso-bidi-font-weight:=
normal'>група.
</b>Засоби, що застосовуються при захворюваннях печінки і жовчовивідних шля=
хів.
Засоби, що застосовуються при <span class=3DSpellE>біліарній</span> патолог=
ії.
Код АТХ А05А Х.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify;layout-grid-mode:char'><sp=
an
lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;layout-grid-mode:char'><sp=
an
class=3DSpellE><b><i>Фармакологічні</i></b></span><b><i> <span class=3DSpel=
lE>властивості</span>.</i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
letter-spacing:
.1pt;mso-ansi-language:UK'>Препарат рослинного походження, що містить екстр=
акт</span><span
lang=3DUK style=3D'mso-ansi-language:UK'> артишоку. Чинить <span style=3D'l=
etter-spacing:
.1pt'>жовчогінну, <span class=3DSpellE>гепатопротекторну</span>, сечогінну =
дію.</span></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Фармакологічний ефект зумовлений комплексом біологічно активних речовин=
, що
входять до складу препарату: <span class=3DSpellE>цинарин</span>, <span
class=3DSpellE>хлорогенова</span> кислота, аскорбінова кислота, каротин, ві=
таміни
групи В, інулін. Основна діюча речовина препарату – <span class=3DSpellE>ци=
нарин</span>
– має переважно <span class=3DSpellE>холеретичну</span> дію. <span class=3D=
SpellE>Холекінетична</span>
дія виражена меншою мірою. Аскорбінова кислота, каротин, вітаміни групи В та
інулін покращують процеси обміну.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Препарат стимулює жовчовиділення, знижує рівень холестерину у крові,
стимулює регенерацію <span class=3DSpellE>гепатоцитів</span>, чинить сечогі=
нну і <span
class=3DSpellE>гіполіпідемічну</span> дію. Зменшує <span style=3D'letter-sp=
acing:
.1pt'>відчуття переповнення або розтягнення шлунка, усуває спазм.</span><o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Сприяє виділенню з організму <span style=3D'letter-spacing:.1pt'>сечови=
ни,
креатиніну, а також токсинів (у т. ч. нітросполук, алкалоїдів, солей важких
металів).</span><o:p></o:p></span></p>

<p class=3D31 style=3D'text-indent:0cm'><span lang=3DUK style=3D'mso-ansi-l=
anguage:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Клінічні характерист=
ики.</span></b><span
lang=3DUK style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Показання.</span>=
</i></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-ansi-lan=
guage:
UK;mso-bidi-font-style:italic'> </span></b><span class=3DSpellE><span lang=
=3DUK
style=3D'mso-ansi-language:UK'>Дискінезія</span></span><span lang=3DUK
style=3D'mso-ansi-language:UK'> жовчних шляхів за гіпотонічно-гіпокінетичним
типом, хронічний <span class=3DSpellE>некалькульозний</span> холецистит,
хронічний гепатит різної етіології, хронічна ниркова недостатність, хронічні
інтоксикації (<span class=3DSpellE>гепатотоксичними</span> речовинами,
нітросполуками, алкалоїдами, солями важких металів), диспепсичні розлади
(важкість в <span class=3DSpellE>епігастрії</span>, метеоризм, нудота, відр=
ижка).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Протипоказання.</=
span></i></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-ansi-lan=
guage:
UK;mso-bidi-font-style:italic'> </span></b><span lang=3DUK style=3D'mso-ans=
i-language:
UK'>Підвищена чутливість до компонентів препарату / інших рослин родини
складноцвітих (айстрових), непрохідність жовчних або сечовивідних шляхів,
нагноєння (емпієма) жовчного міхура, жовчнокам’яна хвороба, гострий гепатит,
тяжка печінкова недостатність, гострі захворювання нирок.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Взаємодія з іншими лікарськими засобами та і=
нші
види взаємодій. </span></i></b><span lang=3DUK style=3D'mso-ansi-language:U=
K'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Якщо пацієнт приймає будь-які інші лікарські
засоби, обов’язково слід проконсультуватися з лікарем щодо можливості
застосування препарату! </span></i><span lang=3DUK style=3D'mso-ansi-langua=
ge:UK'>Препарат
може послаблювати дію антикоагулянтів типу кумарину (<span class=3DSpellE>ф=
енпрокумон</span>,
<span class=3DSpellE>варфарин</span>), що вимагає корекції дози останніх. П=
ри
одночасному застосуванні препарату з <span class=3DSpellE>гіпоазотемічними<=
/span>
і <span class=3DSpellE>гіпохолестеринемічними</span> засобами можливе посил=
ення <span
class=3DSpellE>гіпоазотемічного</span> і <span class=3DSpellE>гіпохолестери=
немічного</span>
ефектів.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<h6 style=3D'margin-left:0cm;text-indent:0cm;mso-list:l0 level6 lfo1'><i><s=
pan
lang=3DUK style=3D'color:windowtext'>Особливості застосування.</span></i><s=
pan
lang=3DUK style=3D'color:windowtext'> <o:p></o:p></span></h6>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:10.0pt;mso-fareast-font-family:Arial;mso-ansi-l=
anguage:
UK'>Перед першим прийомом препарату слід проконсультуватися з лікарем! </sp=
an></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:10.0pt;mso-fareast-font-family:Arial;mso-ansi-l=
anguage:
UK'>Без консультації лікаря не застосовувати препарат довше встановленого
терміну!</span></i></p>

<h6 style=3D'margin-left:0cm;text-indent:0cm;mso-list:l0 level6 lfo1'><i><s=
pan
lang=3DUK style=3D'mso-bidi-font-size:10.0pt;mso-fareast-font-family:Arial;
color:windowtext;font-weight:normal'>Обов’язково слід повідомити лікаря про
попередню реакцію на прийом препаратів цієї групи.</span></i><span lang=3DUK
style=3D'color:windowtext'><o:p></o:p></span></h6>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
10.0pt;mso-fareast-font-family:Arial;mso-ansi-language:UK;mso-bidi-font-sty=
le:
italic'>Застосовувати з обережністю при захворюваннях, що можуть призвести =
до
непрохідності жовчних шляхів та при тяжких захворюваннях печінки. Якщо симп=
томи
захворювання не зникають або постійно <span class=3DSpellE>рецидивують</spa=
n>, а
також у випадку виникнення діареї чи болю в животі лікування препаратом слід
припинити та проконсультуватися з лікарем.</span><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-style:italic'>У</span><span lang=3DUK style=3D'mso-ansi-la=
nguage:
UK'> період лікування слід утримуватися від вживання алкоголю. При тривалому
застосуванні препарату знижується рівень азотовмісних речовин і холестерину=
 у
крові. </span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Препарат містить сорбіт (Е 420). Якщо у пацієнта непереносимість деяких
цукрів, слід проконсультуватися з лікарем, перш ніж приймати цей лікарський
засіб.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Препарат містить <span class=3DSpellE>метилпарабен</span> (Е 218) та <s=
pan
class=3DSpellE>пропілпарабен</span> (Е 216) і може спричинити алергічні реа=
кції
(можливо уповільнені).</span></p>

<h6 style=3D'margin-left:0cm;text-indent:0cm;mso-list:l0 level6 lfo1'><span
lang=3DUK style=3D'mso-bidi-font-size:10.0pt;mso-fareast-font-family:Arial;
color:windowtext;font-weight:normal'>Цей лікарський засіб містить невелику
кількість етанолу (алкоголю), менше 100 мг/дозу.</span><span lang=3DUK
style=3D'color:windowtext'><o:p></o:p></span></h6>

<p class=3DMsoNormal style=3D'text-align:justify'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Застосування у період
вагітності або годування груддю.<b> </b></span></i><span lang=3DUK
style=3D'mso-ansi-language:UK;mso-bidi-font-weight:bold'>Застосування препа=
ра</span><span
lang=3DUK style=3D'mso-ansi-language:UK'>ту у п<span style=3D'mso-bidi-font=
-weight:
bold'>еріод вагітності можливе за призначенням лікаря тільки тоді, коли
очікувана користь для матері перевищує потенційний ризик для плода. </span>=
</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-weight:bold'>У разі необхідності застосування препарату
годування груддю слід припинити.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
14.5pt;mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Здатність впливати на
швидкість реакції при керуванні автотранспортом або іншими механізмами.<b> =
</b></span></i><span
lang=3DUK style=3D'mso-ansi-language:UK'>Не впливає.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
14.5pt;mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-line-height-alt:5.0pt'=
><b><i><span
lang=3DUK style=3D'letter-spacing:-.2pt;mso-ansi-language:UK'>Спосіб застос=
ування
та дози.</span></i></b><b><span lang=3DUK style=3D'letter-spacing:-.2pt;mso=
-ansi-language:
UK'> </span></b><i><span lang=3DUK style=3D'letter-spacing:-.2pt;mso-ansi-l=
anguage:
UK'>Дозу та тривалість застосування лікар встановлює індивідуально<span
style=3D'mso-spacerun:yes'>  </span>залежно від тяжкості захворювання!</spa=
n></i><span
lang=3DUK style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-line-height-alt:5.0pt'=
><span
lang=3DUK style=3D'letter-spacing:-.2pt;mso-ansi-language:UK'>Перед застосу=
ванням
препарат потрібно збовтати та розвести необхідну кількість розчину у 2 стол=
ових
ложках (30 мл) води.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-line-height-alt:5.0pt'=
><span
lang=3DUK style=3D'letter-spacing:-.2pt;mso-ansi-language:UK'>Приймати за 1=
5</span><span
lang=3DUK style=3D'mso-fareast-font-family:"Times New Roman";mso-bidi-font-=
family:
"Times New Roman";letter-spacing:-.2pt;mso-ansi-language:UK'>–</span><span
lang=3DUK style=3D'letter-spacing:-.2pt;mso-ansi-language:UK'>30 хвилин до =
їди. </span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Дорослим і дітям віком від 12 років – по 2</span><span lang=3DUK
style=3D'mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Ti=
mes New Roman";
mso-ansi-language:UK'>–</span><span lang=3DUK style=3D'mso-ansi-language:UK=
'>3 мл 3
рази на добу.</span></p>

<p class=3DMsoBodyText style=3D'margin-bottom:0cm;margin-bottom:.0001pt'><s=
pan
lang=3DUK style=3D'mso-ansi-language:UK'>Дітям віком від 6 до 12 років – по=
 1 мл 3
рази на добу.</span></p>

<p class=3DMsoBodyText style=3D'margin-bottom:0cm;margin-bottom:.0001pt'><s=
pan
lang=3DUK style=3D'mso-ansi-language:UK'>Тривалість курсу лікування станови=
ть 2</span><span
lang=3DUK style=3D'mso-fareast-font-family:"Times New Roman";mso-bidi-font-=
family:
"Times New Roman";mso-ansi-language:UK'>–</span><span lang=3DUK style=3D'ms=
o-ansi-language:
UK'>4 тижні. Лікування можна повторити після перерви в 1</span><span lang=
=3DUK
style=3D'mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Ti=
mes New Roman";
mso-ansi-language:UK'>–</span><span lang=3DUK style=3D'mso-ansi-language:UK=
'>2
місяці, погодивши з лікарем.</span></p>

<p class=3DMsoBodyText style=3D'margin-bottom:0cm;margin-bottom:.0001pt'><o=
:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Діти.</span></i><b><span lang=3DUK style=3D'=
mso-ansi-language:
UK'> </span></b><span lang=3DUK style=3D'mso-ansi-language:UK'>Застосовуват=
и дітям
віком від 6 років.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Передозування.</span></i></b><span lang=3DUK
style=3D'mso-ansi-language:UK'> Випадки передозування не описані. Можливе
посилення побічних реакцій препарату.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Лікування: </span></i><span lang=3DUK
style=3D'mso-ansi-language:UK'>відміна препарату, промивання шлунка,
симптоматична терапія. Специфічний антидот відсутній.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Побічні реакції.<=
/span></i></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-ansi-lan=
guage:
UK'> </span></b><span lang=3DUK style=3D'mso-ansi-language:UK'>При тривалому
застосуванні препарату у високих дозах можливі діарея, біль у верхній части=
ні
живота, нудота і печія, алергічні реакції. <i>У разі виникнення будь-яких
незвичних реакцій обов</i></span><i><span lang=3DUK style=3D'mso-fareast-fo=
nt-family:
"Times New Roman";mso-bidi-font-family:"Times New Roman";mso-ansi-language:
UK'>’</span></i><i><span lang=3DUK style=3D'mso-ansi-language:UK'>язково сл=
ід
порадитися з лікарем щодо подальшого застосування препарату.</span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Термін придатност=
і. </span></i></b><span
lang=3DUK style=3D'mso-ansi-language:UK'>2 роки.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-fareast-language:UK;mso-bidi-font-weight:bold'>Термін придатності пі=
сля
розкриття флакону – 28 </span><span lang=3DUK style=3D'mso-ansi-language:UK;
mso-bidi-font-weight:bold'>діб при зберіганні при температурі не вище 25 °С=
.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;layout-grid-mode:char'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-ansi-lan=
guage:
UK'>Умови зберігання. </span></b><span lang=3DUK style=3D'mso-ansi-language=
:UK'>Зберігати
в оригінальній упаковці при температурі не вище 25 &ordm;С.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify;layout-grid-mode:char'><sp=
an
lang=3DUK style=3D'mso-ansi-language:UK'>Зберігати у недоступному для дітей=
 місці.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Упаковка. </span></b=
><span
lang=3DUK style=3D'mso-ansi-language:UK'>По 100 мл препарату у полімерних ф=
лаконах,
закритих кришками. Кожен флакон з дозуючим пристроєм у коробці з картону.</=
span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Категорія відпуску. =
</span></b><span
lang=3DUK style=3D'mso-ansi-language:UK'>Без рецепта.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'>Виробник. </span></b><span lang=3DUK
style=3D'mso-ansi-language:UK'>Товариство з обмеженою відповідальністю
«Харківське фармацевтичне підприємство «Здоров’я народу».</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK;mso-bidi-font-style:i=
talic'>Місцезнаходження
виробника та його адреса місця провадження діяльності.</span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-weight:bold'>Україна, 61002, Харківська обл., місто Харків,
вулиця <span class=3DSpellE>Куликівська</span>, будинок 41.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-weight:bold'>Виробництво з продукції </span><span lang=3DE=
N-US
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>in</span><span
lang=3DEN-US style=3D'mso-ansi-language:UK;mso-bidi-font-weight:bold'> </sp=
an><span
lang=3DEN-US style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>bu=
lk</span><span
lang=3DUK style=3D'mso-ansi-language:UK;mso-bidi-font-weight:bold'> фірми</=
span><span
lang=3DUK style=3D'mso-ansi-language:UK'> ТОВ «Фармацевтична компанія «Здор=
ов’я»,
Україна.</span></p>

</div>

</body>

</html>

------=_NextPart_01D5E6AB.B1F29980
Content-Location: file:///C:/68099CA5/UA179260101_1ECE.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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------=_NextPart_01D5E6AB.B1F29980
Content-Location: file:///C:/68099CA5/UA179260101_1ECE.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D5E6AB.B1F29980
Content-Location: file:///C:/68099CA5/UA179260101_1ECE.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D5E6AB.B1F29980
Content-Location: file:///C:/68099CA5/UA179260101_1ECE.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA179260101_1ECE.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D5E6AB.B1F29980--
